The role of beta 2 integrins in macrophage fusion
The role of beta 2 integrins in macrophage fusion
批准号:
10545168
负责人:
Tatiana P Ugarova
金额:
$44.68万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-07-01 至 2024-04-30
关键词:
ActinsAdherens JunctionAdhesivesAdsorptionAffectAfibrinogenemiaArtificial ImplantsAttenuatedBinding SitesBiocompatible MaterialsBiologicalBiologyCD18 AntigensCD47 geneCell SurvivalCell membraneChronicComplexDataDefectDepositionDissectionE-CadherinEndogenous RetrovirusesEnzymesEpitheliumEventExtracellular SpaceFailureFibrinFibrinogenFluorescenceForeign BodiesForeign-Body ReactionGene TargetingGenesGiant CellsGoalsGrantGranulation TissueImaging TechniquesImmunoelectron MicroscopyImplantIn VitroInflammationIntegrinsKnock-outKnowledgeLigandsMacrophageMacrophage-1 AntigenMedical DeviceMicrofluidic MicrochipsMicrofluidicsMicroscopyModelingMolecularMusMyeloid CellsNanotechnologyPTPNS1 genePhenotypePlasma ProteinsPolymersPropertyProsthesis ImplantationProteinsProteomicsRecording of previous eventsResearchResolutionRoleStructureSurfaceSystemTestingThickTimeTranslatingVascular GraftVideo MicroscopyWild Type Mouseadhesion receptorbiomaterial developmentexperimental studyhigh resolution imagingimplantationin vitro Modelin vivoknock-downlive cell imagingmechanical propertiesmouse modelnectinnovelpolymerizationprotein Ereceptorresponsesyncytintechnological innovation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Macrophage fusion resulting in the formation of multinucleated giant cells (MGCs) accompanies a
variety of maladies associated with chronic inflammation, including the foreign body response (FBR)
elicited by implanted biomaterials. Despite the long history of research on FBR, the molecular and
cellular mechanisms of macrophage fusion, an event central to the long-term failure of implanted
prosthetic vascular grafts and other medical devices, remain poorly understood. In our preliminary
studies using in vivo implantation model, we found that the formation of MGCs and granulation tissue,
which develops around the implant and is a precursor of the undesirable fibrotic cap, was almost
completely abolished in fibrinogen-deficient mice. Surprisingly, the number of MGCs formed on
biomaterials implanted into Mac-1-deficient mice was greater than in wild-type mice and the thickness
of granulation tissue was larger. We hypothesize that macrophage fusion on biomaterials critically
depends on the deposited fibrin(ogen) matrix and the absence of Mac-1, through the alteration of
adhesive properties of macrophages, exacerbates the FBR. Specific Aim 1 is to test this hypothesis.
Using a mouse model of biomaterial implantation and gene-targeted mice, we will perform systematic
analyses of the early and late stages of FBR and determine the M1/M2 phenotype of MGCs derived
from wild-type and Mac-1-deficient macrophages. Using nanotechnology approaches we will
characterize the adhesive and mechanical properties of fibrin(ogen) matrices deposited on biomaterials
in wild-type and Mac-1-deficient mice. Specific Aim 2 will characterize previously unrecognized actin-
based zipper-like structures (ZLS) that form between MGCs on implanted biomaterials. We developed
an in vitro model that reproduces the formation of ZLS and demonstrated that the intercellular space
within ZLS is filled with junctional proteins E-cadherin and nectin-2. We hypothesize that MGCs form
epithelial-like junctions that aid the MGC survival. Taking advantage of technological innovations
including a microfluidic chamber that allows the precise dissection of ZLS followed by proteomics
analyses, high-resolution microscopy, live cell imaging and mice with myeloid cell-specific KO of E-
cadherin and other components of junctions, we will determine the composition of ZLS and their role in
the FBR. Specific Aim 3 is to determine the role of authentic fusogenic proteins syncytins in
macrophage fusion. Based on our finding that macrophage fusion is initiated by an actin-based
protrusion, we will use knockdown experiments, EM and video microscopy to test the hypothesis that a
fusion-competent protrusion at the leading edge of a donor macrophage contains syncytins. Overalls,
these studies will define the novel biology of macrophage fusion and characterize new mechanisms that
have the potential to modulate the FBR.
期刊论文(35)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.yexcr.2008.05.016
发表时间:
2008-08
期刊:
Experimental cell research
影响因子:
3.7
作者:
[V. Yakubenko;N. Belevych;D. Mishchuk;A. Schurin;S. Lam;T. Ugarova]
通讯作者:
V. Yakubenko;N. Belevych;D. Mishchuk;A. Schurin;S. Lam;T. Ugarova
DOI:
10.1021/bi051581d
发表时间:
2005-12
期刊:
Biochemistry
影响因子:
2.9
作者:
[Nataly P. Podolnikova;O. Gorkun;R. Loreth;V. Yee;S. Lord;T. Ugarova]
通讯作者:
Nataly P. Podolnikova;O. Gorkun;R. Loreth;V. Yee;S. Lord;T. Ugarova
DOI:
10.1160/th09-07-0447
发表时间:
2010-07
期刊:
Thrombosis and haemostasis
影响因子:
6.7
作者:
[Derkach DN, Wadekar SA, Perkins KB, Rousseau E, Dreiza CM, Cheung-Flynn J, Ramos HC, Ugarova TP, Sheller MR]
通讯作者:
Sheller MR
DOI:
10.1091/mbc.e19-12-0707
发表时间:
2020-08-15
期刊:
Molecular biology of the cell
影响因子:
3.3
作者:
[Balabiyev A, Podolnikova NP, Mursalimov A, Lowry D, Newbern JM, Roberson RW, Ugarova TP]
通讯作者:
Ugarova TP
PLATELET FACTOR 4 (PF4) IMPROVES SURVIVAL IN A MURINE MODEL OF ANTIBIOTIC-SUSCEPTIBLE AND METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS PERITONITIS.
血小板因子 4 (PF4) 可提高抗生素敏感且耐甲氧西林金黄色葡萄球菌腹膜炎小鼠模型的存活率。
DOI:
10.1101/2023.08.25.554865
发表时间:
2023
期刊:
bioRxiv : the preprint server for biology
影响因子:
--
作者:
[Podolnikova,NatalyP, Lishko,ValeryiK, Roberson,Robert, Koh,Zhqian, Derkach,Dmitry, Richardson,David, Sheller,Michael, Ugarova,TatianaP]
通讯作者:
Ugarova,TatianaP
共 16 条
RECOGNITION OF FIBRINOGEN BY LEUKOCYTE INTERGRINS
-
批准号:6390461
-
项目类别:
-
资助金额:$22.7万
-
财政年份:1999
-
负责人:Tatiana P Ugarova
-
依托单位:
Recognition of Fibrinogen by Leukocyte Integrins
-
批准号:8197907
-
项目类别:
-
资助金额:$38.13万
-
财政年份:1999
-
负责人:Tatiana P Ugarova
-
依托单位:
Recognition of Fibrinogen by Leukocyte Integrins
-
批准号:8386971
-
项目类别:
-
资助金额:$36.3万
-
财政年份:1999
-
负责人:Tatiana P Ugarova
-
依托单位:
The role of beta 2 integrins in macrophage fusion
-
批准号:9888193
-
项目类别:
-
资助金额:$47.97万
-
财政年份:1999
-
负责人:Tatiana P Ugarova
-
依托单位:
The role of beta 2 integrins in macrophage fusion
-
批准号:10082459
-
项目类别:
-
资助金额:$47.97万
-
财政年份:1999
-
负责人:Tatiana P Ugarova
-
依托单位:
RECOGNITION OF FIBRINOGEN BY LEUKOCYTE INTERGRINS
-
批准号:6184837
-
项目类别:
-
资助金额:$22.04万
-
财政年份:1999
-
负责人:Tatiana P Ugarova
-
依托单位:
RECOGNITION OF FIBRINOGEN BY LEUKOCYTE INTERGRINS
-
批准号:6537649
-
项目类别:
-
资助金额:$23.38万
-
财政年份:1999
-
负责人:Tatiana P Ugarova
-
依托单位:
Recognition of fibrinogen by leukocyte integrins
-
批准号:6917095
-
项目类别:
-
资助金额:$30.6万
-
财政年份:1999
-
负责人:Tatiana P Ugarova
-
依托单位:
Recognition of Fibrinogen by Leukocyte Integrins
-
批准号:8039061
-
项目类别:
-
资助金额:$38.13万
-
财政年份:1999
-
负责人:Tatiana P Ugarova
-
依托单位:
Recognition of fibrinogen by leukocyte integrins
-
批准号:7447379
-
项目类别:
-
资助金额:$28.35万
-
财政年份:1999
-
负责人:Tatiana P Ugarova
-
依托单位:
Recognition of fibrinogen by leukocyte integrins
-
批准号:7260330
-
项目类别:
-
资助金额:$28.35万
-
财政年份:1999
-
负责人:Tatiana P Ugarova
-
依托单位:
Recognition of fibrinogen by leukocyte integrins
-
批准号:7336933
-
项目类别:
-
资助金额:$29.88万
-
财政年份:1999
-
负责人:Tatiana P Ugarova
-
依托单位:
Recognition of Fibrinogen by Leukocyte Integrins
-
批准号:8585079
-
项目类别:
-
资助金额:$37.36万
-
财政年份:1999
-
负责人:Tatiana P Ugarova
-
依托单位:
Role of beta 2 integrins in macrophage fusion
-
批准号:9127306
-
项目类别:
-
资助金额:$38.63万
-
财政年份:1999
-
负责人:Tatiana P Ugarova
-
依托单位:
The role of beta 2 integrins in macrophage fusion
-
批准号:10323008
-
项目类别:
-
资助金额:$47.97万
-
财政年份:1999
-
负责人:Tatiana P Ugarova
-
依托单位:
Recognition of fibrinogen by leukocyte integrins
-
批准号:7079277
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1999
-
负责人:Tatiana P Ugarova
-
依托单位:
RECOGNITION OF FIBRINOGEN BY LEUKOCYTE INTERGRINS
-
批准号:2892886
-
项目类别:
-
资助金额:$22.66万
-
财政年份:1999
-
负责人:Tatiana P Ugarova
-
依托单位:
Recognition of fibrinogen by leukocyte integrins
-
批准号:6779338
-
项目类别:
-
资助金额:$33.1万
-
财政年份:1999
-
负责人:Tatiana P Ugarova
-
依托单位:
海外基金